Posted by Michael Wonder on 10 Dec 2019
Ovarian cancer drug olaparib approved in Scotland as new treatment
9 December 2019 - A maintenance treatment for patients with advanced ovarian cancer has been approved for use in Scotland.
Olaparib tablets will now be available for patients with newly-diagnosed BRCA-mutated advanced ovarian cancer who have responded to chemotherapy.
A trial has found that for those taking tablets, it can be three years before the disease progresses.
